Cited by 680Angiogenesis and VEGF in CancerNeurological Disease Mechanisms and TreatmentsBarrier Structure and Function Studies

Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia

Open access
Marti, Hugo J.H., Bernaudin, Myriam, Bellail, Anita, Schoch, Heike, Euler, Monika, Petit, Edwige, Risau, Werner·2000·The American Journal of Pathology

Abstract

We investigated the hypothesis that hypoxia induces angiogenesis and thereby may counteract the detrimental neurological effects associated with stroke. Forty-eight to seventy-two hours after permanent middle cerebral artery occlusion we found a strong increase in the number of newly formed vessels at the border of the infarction. Using the hypoxia marker nitroimidazole EF5, we detected hypoxic cells in the ischemic border of the neocortex. Expression of vascular endothelial growth factor (VEGF), which is the main regulator of angiogenesis and is inducible by hypoxia, was strongly up-regulated in the ischemic border, at times between 6 and 24 hours after occlusion. In addition, both VEGF receptors (VEGFRs) were up-regulated at the border after 48 hours and later in the ischemic core. Finally, the two transcription factors, hypoxia-inducible factor-1 (HIF-1) and HIF-2, known to be involved in the regulation of VEGF and VEGFR gene expression, were increased in the ischemic border after 72 hours, suggesting a regulatory function for these factors. These results strongly suggest that the VEGF/VEGFR system, induced by hypoxia, leads to the growth of new vessels after cerebral ischemia. Exogenous support of this natural protective mechanism might lead to enhanced survival after stroke.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0002-9440(10)64964-4

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Schulz JB, Weller M, Moskowitz MA: Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol 1999, 45:421- 429

Cited by

Sorted by citations

Authors
Marti, H. J. H., Bernaudin, M., Bellail, A., Schoch, H., Euler, M., Petit, E., & Risau, W.
Affiliations
Centre National de la Recherche Scientifique (FR)
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2000-03
Volume
156
Issue
3
Pages
965-976
ISSN
0002-9440 (ISSN-L)
OpenAlex
W2001500938
Cited by
680
References
71
Citations by year
2026: 14 · 2025: 28 · 2024: 11 · 2023: 13 · 2022: 15 · 2021: 22 · 2020: 21 · 2019: 24 · 2018: 28 · 2017: 24 · 2016: 36 · 2015: 31 · 2014: 31 · 2013: 39 · 2012: 42
FWCI
8.08
Type
journal article
Language
en
Open access
Locations
  • American Journal Of Pathology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ministerio de Economía y Competitividad
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
hypoxia, vascular endothelial growth factor, angiogenesis, neovascularization, cerebral ischemia, stroke, middle cerebral artery occlusion, VEGF receptors, HIF-1, HIF-2, ischemic border zone, ischemic core, neuroprotection
MeSH terms
Animals, Hypoxia, Brain Ischemia, Disease Models, Animal, DNA, DNA-Binding Proteins, Immunohistochemistry, Lymphokines, Neovascularization, Pathologic, Nuclear Proteins, Peptide Initiation Factors, Proto-Oncogene Proteins, RNA, Messenger, Transcription Factors, Up-Regulation, Endothelial Growth Factors, In Situ Hybridization, DNA Primers, Receptors, Growth Factor, Ki-67 Antigen, Platelet Endothelial Cell Adhesion Molecule-1, Reverse Transcriptase Polymerase Chain Reaction, Receptor Protein-Tyrosine Kinases, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-1, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review